Northern Mariana Islands

Northern Mariana Islands

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.08 (5.89 - 8.14) 2019 Modelled IHME
7.27 (6.13 - 8.40) 2018 Modelled IHME
7.35 (6.15 - 8.62) 2017 Modelled IHME
7.32 (6.14 - 8.56) 2016 Modelled IHME
7.28 (6.05 - 8.63) 2015 Modelled IHME
7.23 (6.03 - 8.57) 2014 Modelled IHME
7.17 (5.99 - 8.48) 2013 Modelled IHME
7.11 (5.95 - 8.42) 2012 Modelled IHME
7.05 (5.89 - 8.45) 2011 Modelled IHME
6.99 (5.77 - 8.58) 2010 Modelled IHME
6.93 (5.78 - 8.43) 2009 Modelled IHME
6.87 (5.77 - 8.25) 2008 Modelled IHME
6.81 (5.70 - 8.12) 2007 Modelled IHME
6.75 (5.61 - 7.96) 2006 Modelled IHME
6.69 (5.49 - 7.86) 2005 Modelled IHME
6.62 (5.49 - 7.72) 2004 Modelled IHME
6.54 (5.42 - 7.62) 2003 Modelled IHME
6.46 (5.36 - 7.58) 2002 Modelled IHME
6.4 (5.30 - 7.50) 2001 Modelled IHME
6.37 (5.28 - 7.53) 2000 Modelled IHME
6.39 (5.34 - 7.52) 1999 Modelled IHME
6.44 (5.40 - 7.56) 1998 Modelled IHME
6.49 (5.46 - 7.60) 1997 Modelled IHME
6.54 (5.52 - 7.64) 1996 Modelled IHME
6.56 (5.51 - 7.62) 1995 Modelled IHME
6.56 (5.53 - 7.55) 1994 Modelled IHME
6.56 (5.49 - 7.54) 1993 Modelled IHME
6.55 (5.46 - 7.54) 1992 Modelled IHME
6.54 (5.38 - 7.54) 1991 Modelled IHME
6.52 (5.28 - 7.54) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.55 (1.78 - 3.52) 2019 Modelled IHME
2.57 (1.77 - 3.42) 2018 Modelled IHME
2.58 (1.75 - 3.43) 2017 Modelled IHME
2.58 (1.78 - 3.43) 2016 Modelled IHME
2.58 (1.78 - 3.47) 2015 Modelled IHME
2.57 (1.77 - 3.46) 2014 Modelled IHME
2.55 (1.75 - 3.45) 2013 Modelled IHME
2.53 (1.71 - 3.42) 2012 Modelled IHME
2.51 (1.68 - 3.39) 2011 Modelled IHME
2.51 (1.66 - 3.38) 2010 Modelled IHME
2.51 (1.67 - 3.37) 2009 Modelled IHME
2.53 (1.70 - 3.36) 2008 Modelled IHME
2.55 (1.73 - 3.38) 2007 Modelled IHME
2.57 (1.76 - 3.40) 2006 Modelled IHME
2.57 (1.77 - 3.44) 2005 Modelled IHME
2.54 (1.74 - 3.39) 2004 Modelled IHME
2.47 (1.69 - 3.30) 2003 Modelled IHME
2.39 (1.61 - 3.19) 2002 Modelled IHME
2.32 (1.56 - 3.11) 2001 Modelled IHME
2.29 (1.53 - 3.11) 2000 Modelled IHME
2.32 (1.56 - 3.13) 1999 Modelled IHME
2.38 (1.60 - 3.17) 1998 Modelled IHME
2.45 (1.65 - 3.25) 1997 Modelled IHME
2.51 (1.69 - 3.37) 1996 Modelled IHME
2.54 (1.71 - 3.42) 1995 Modelled IHME
2.54 (1.71 - 3.39) 1994 Modelled IHME
2.53 (1.71 - 3.35) 1993 Modelled IHME
2.51 (1.70 - 3.32) 1992 Modelled IHME
2.48 (1.70 - 3.28) 1991 Modelled IHME
2.43 (1.69 - 3.22) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
59 (49 - 69) 2019 Modelled IHME
59 (50 - 69) 2018 Modelled IHME
60 (50 - 69) 2017 Modelled IHME
60 (51 - 69) 2016 Modelled IHME
60 (51 - 70) 2015 Modelled IHME
61 (52 - 70) 2014 Modelled IHME
61 (52 - 70) 2013 Modelled IHME
61 (53 - 70) 2012 Modelled IHME
61 (53 - 70) 2011 Modelled IHME
62 (53 - 70) 2010 Modelled IHME
62 (54 - 70) 2009 Modelled IHME
62 (54 - 70) 2008 Modelled IHME
62 (54 - 70) 2007 Modelled IHME
62 (54 - 70) 2006 Modelled IHME
62 (54 - 70) 2005 Modelled IHME
62 (54 - 70) 2004 Modelled IHME
62 (54 - 69) 2003 Modelled IHME
62 (54 - 69) 2002 Modelled IHME
62 (54 - 69) 2001 Modelled IHME
62 (54 - 69) 2000 Modelled IHME
61 (53 - 69) 1999 Modelled IHME
61 (53 - 68) 1998 Modelled IHME
60 (52 - 68) 1997 Modelled IHME
60 (52 - 68) 1996 Modelled IHME
60 (52 - 68) 1995 Modelled IHME
60 (52 - 68) 1994 Modelled IHME
60 (52 - 68) 1993 Modelled IHME
61 (53 - 69) 1992 Modelled IHME
61 (53 - 70) 1991 Modelled IHME
61 (53 - 70) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.55 (0.45 - 0.68) 2019 Modelled IHME
0.55 (0.44 - 0.67) 2018 Modelled IHME
0.55 (0.44 - 0.67) 2017 Modelled IHME
0.54 (0.44 - 0.66) 2016 Modelled IHME
0.54 (0.44 - 0.67) 2015 Modelled IHME
0.54 (0.44 - 0.66) 2014 Modelled IHME
0.54 (0.44 - 0.67) 2013 Modelled IHME
0.54 (0.44 - 0.67) 2012 Modelled IHME
0.54 (0.44 - 0.67) 2011 Modelled IHME
0.54 (0.43 - 0.67) 2010 Modelled IHME
0.54 (0.43 - 0.66) 2009 Modelled IHME
0.54 (0.42 - 0.66) 2008 Modelled IHME
0.53 (0.42 - 0.65) 2007 Modelled IHME
0.53 (0.42 - 0.65) 2006 Modelled IHME
0.53 (0.42 - 0.64) 2005 Modelled IHME
0.53 (0.42 - 0.65) 2004 Modelled IHME
0.54 (0.43 - 0.67) 2003 Modelled IHME
0.56 (0.44 - 0.68) 2002 Modelled IHME
0.57 (0.45 - 0.70) 2001 Modelled IHME
0.57 (0.45 - 0.71) 2000 Modelled IHME
0.57 (0.46 - 0.71) 1999 Modelled IHME
0.58 (0.46 - 0.71) 1998 Modelled IHME
0.58 (0.46 - 0.71) 1997 Modelled IHME
0.58 (0.46 - 0.71) 1996 Modelled IHME
0.58 (0.46 - 0.71) 1995 Modelled IHME
0.58 (0.46 - 0.71) 1994 Modelled IHME
0.58 (0.46 - 0.72) 1993 Modelled IHME
0.58 (0.46 - 0.72) 1992 Modelled IHME
0.58 (0.47 - 0.72) 1991 Modelled IHME
0.58 (0.47 - 0.73) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
16 (10 - 24) 2019 Modelled IHME
16 (10 - 23) 2018 Modelled IHME
16 (10 - 22) 2017 Modelled IHME
16 (10 - 22) 2016 Modelled IHME
16 (10 - 22) 2015 Modelled IHME
15 (10 - 22) 2014 Modelled IHME
15 (10 - 21) 2013 Modelled IHME
15 (10 - 21) 2012 Modelled IHME
15 (10 - 21) 2011 Modelled IHME
15 (10 - 20) 2010 Modelled IHME
15 (10 - 20) 2009 Modelled IHME
15 (10 - 20) 2008 Modelled IHME
14 (10 - 20) 2007 Modelled IHME
14 (10 - 20) 2006 Modelled IHME
14 (10 - 20) 2005 Modelled IHME
14 (10 - 19) 2004 Modelled IHME
14 (10 - 19) 2003 Modelled IHME
14 (10 - 19) 2002 Modelled IHME
14 (10 - 19) 2001 Modelled IHME
14 (10 - 20) 2000 Modelled IHME
15 (10 - 20) 1999 Modelled IHME
15 (10 - 21) 1998 Modelled IHME
15 (11 - 21) 1997 Modelled IHME
16 (11 - 21) 1996 Modelled IHME
16 (11 - 21) 1995 Modelled IHME
16 (11 - 21) 1994 Modelled IHME
16 (11 - 21) 1993 Modelled IHME
16 (10 - 21) 1992 Modelled IHME
15 (10 - 21) 1991 Modelled IHME
16 (10 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Overview

Prevalence (national)

Modelled

HBV (HBsAg+)
7.08 (%)
2019
(5.89 - 8.14(%))
IHME
HCV (RNA/cAg+)
0.55 (%)
2019
(0.45 - 0.68(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
8
2019
(6 - 10)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3
2019
(2 - 5)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
2.55 (%)
2019, latest modelled
(1.78 - 3.52(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners